cis-JB253   Click here for help

GtoPdb Ligand ID: 7787

Compound class: Synthetic organic
Comment: cis-JB253 is described in [1]. The structure is based upon that of the diabetes sulfonylurea drug glimepiride. This compound is formed from trans-JB253 upon photoisomerization using blue light. This isomerization process is reversible. The molecule is active in the cis-state, increasing insulin production from pancreatic B-cells in vitro. It is postulated that this type of photoswitchable compound could in the future, allow better control of blood glucose in diabetic patients [1].
Note that the PubChem CID we link to does not specify the cis-trans state of the compound.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 2
Rotatable bonds 10
Topological polar surface area 111.61
Molecular weight 457.21
XLogP 6.26
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCN(c1ccc(cc1)N=Nc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1)CC
Isomeric SMILES CCN(c1ccc(cc1)/N=N\c1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1)CC
InChI InChI=1S/C23H31N5O3S/c1-3-28(4-2)21-14-10-19(11-15-21)25-26-20-12-16-22(17-13-20)32(30,31)27-23(29)24-18-8-6-5-7-9-18/h10-18H,3-9H2,1-2H3,(H2,24,27,29)/b26-25-
InChI Key FCHDFDWESRUUDK-QPLCGJKRSA-N
References
1. Broichhagen J, Schönberger M, Cork SC, Frank JA, Marchetti P, Bugliani M, Shapiro AM, Trapp S, Rutter GA, Hodson DJ et al.. (2014)
Optical control of insulin release using a photoswitchable sulfonylurea.
Nat Commun, 5: 5116. [PMID:25311795]
2. Picard A, Moullé VS, Le Foll C, Cansell C, Véret J, Coant N, Le Stunff H, Migrenne S, Luquet S, Cruciani-Guglielmacci C et al.. (2014)
Physiological and pathophysiological implications of lipid sensing in the brain.
Diabetes Obes Metab, 16 Suppl 1: 49-55. [PMID:25200296]
3. Tsuboi T, Rutter GA. (2003)
Multiple forms of "kiss-and-run" exocytosis revealed by evanescent wave microscopy.
Curr Biol, 13 (7): 563-7. [PMID:12676086]